Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 24 studies | 28% ± 10% | |
conventional dendritic cell | 20 studies | 35% ± 10% | |
classical monocyte | 20 studies | 32% ± 14% | |
mast cell | 16 studies | 32% ± 11% | |
monocyte | 14 studies | 27% ± 9% | |
non-classical monocyte | 12 studies | 32% ± 17% | |
myeloid cell | 9 studies | 34% ± 17% | |
dendritic cell | 8 studies | 47% ± 24% | |
type I pneumocyte | 7 studies | 25% ± 11% | |
platelet | 7 studies | 37% ± 15% | |
fibroblast | 6 studies | 21% ± 7% | |
hematopoietic precursor cell | 5 studies | 39% ± 16% | |
epithelial cell | 5 studies | 25% ± 7% | |
endothelial cell | 5 studies | 21% ± 3% | |
microglial cell | 5 studies | 22% ± 10% | |
mononuclear phagocyte | 4 studies | 35% ± 14% | |
leukocyte | 4 studies | 24% ± 7% | |
hematopoietic stem cell | 4 studies | 32% ± 7% | |
megakaryocyte | 4 studies | 45% ± 18% | |
basal cell | 4 studies | 23% ± 11% | |
common myeloid progenitor | 3 studies | 45% ± 9% | |
myofibroblast cell | 3 studies | 19% ± 2% | |
endothelial cell of lymphatic vessel | 3 studies | 22% ± 1% | |
connective tissue cell | 3 studies | 21% ± 2% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 35% ± 9% | |
neutrophil | 3 studies | 20% ± 4% | |
smooth muscle cell | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 99% | 1683.35 | 1796 / 1809 | 100% | 221.00 | 471 / 472 |
kidney | 100% | 966.66 | 89 / 89 | 99% | 90.02 | 892 / 901 |
breast | 100% | 1469.57 | 459 / 459 | 98% | 74.01 | 1101 / 1118 |
ovary | 98% | 649.03 | 176 / 180 | 100% | 76.54 | 429 / 430 |
lung | 100% | 1786.40 | 577 / 578 | 97% | 76.05 | 1122 / 1155 |
liver | 100% | 1120.27 | 226 / 226 | 96% | 65.70 | 388 / 406 |
uterus | 99% | 1345.21 | 169 / 170 | 96% | 84.85 | 441 / 459 |
intestine | 100% | 1530.99 | 966 / 966 | 94% | 97.59 | 496 / 527 |
thymus | 97% | 622.48 | 635 / 653 | 95% | 45.56 | 575 / 605 |
bladder | 100% | 1430.71 | 21 / 21 | 91% | 72.95 | 459 / 504 |
prostate | 98% | 808.39 | 239 / 245 | 92% | 34.22 | 460 / 502 |
stomach | 94% | 830.13 | 338 / 359 | 93% | 86.25 | 265 / 286 |
adrenal gland | 99% | 835.65 | 256 / 258 | 77% | 30.11 | 176 / 230 |
esophagus | 83% | 950.99 | 1206 / 1445 | 91% | 56.06 | 166 / 183 |
pancreas | 58% | 309.89 | 190 / 328 | 95% | 81.36 | 169 / 178 |
adipose | 100% | 1747.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 183.51 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 60.57 | 29 / 29 |
spleen | 100% | 2777.73 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 70.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 48.03 | 1 / 1 |
blood vessel | 100% | 1910.31 | 1331 / 1335 | 0% | 0 | 0 / 0 |
brain | 22% | 93.72 | 594 / 2642 | 65% | 38.72 | 460 / 705 |
peripheral blood | 81% | 3817.92 | 756 / 929 | 0% | 0 | 0 / 0 |
heart | 75% | 467.20 | 650 / 861 | 0% | 0 | 0 / 0 |
muscle | 10% | 36.94 | 80 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035646 | Biological process | endosome to melanosome transport |
GO_0090382 | Biological process | phagosome maturation |
GO_0006886 | Biological process | intracellular protein transport |
GO_0032438 | Biological process | melanosome organization |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0007005 | Biological process | mitochondrion organization |
GO_0019882 | Biological process | antigen processing and presentation |
GO_0072657 | Biological process | protein localization to membrane |
GO_1903232 | Biological process | melanosome assembly |
GO_0012505 | Cellular component | endomembrane system |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005769 | Cellular component | early endosome |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0033162 | Cellular component | melanosome membrane |
GO_0044233 | Cellular component | mitochondria-associated endoplasmic reticulum membrane contact site |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0031905 | Cellular component | early endosome lumen |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0042470 | Cellular component | melanosome |
GO_0035612 | Molecular function | AP-2 adaptor complex binding |
GO_0030742 | Molecular function | GTP-dependent protein binding |
GO_0035651 | Molecular function | AP-3 adaptor complex binding |
GO_0005525 | Molecular function | GTP binding |
GO_0036461 | Molecular function | BLOC-2 complex binding |
GO_0035650 | Molecular function | AP-1 adaptor complex binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAB32 |
Protein name | Ras-related protein Rab-32 |
Synonyms | |
Description | FUNCTION: Acts as an A-kinase anchoring protein by binding to the type II regulatory subunit of protein kinase A and anchoring it to the mitochondrion. Also involved in synchronization of mitochondrial fission . Plays a role in the maturation of phagosomes that engulf pathogens, such as S.aureus and M.tuberculosis . Plays an important role in the control of melanin production and melanosome biogenesis . In concert with RAB38, regulates the proper trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes (By similarity). . |
Accessions | Q13637 ENST00000367495.4 |